STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.
Autor: | Marozin, S1, Altomonte, J1, Muñoz-Álvarez, K A1, Rizzani, A2, De Toni, E N2, Thasler, W E3, Schmid, R M1, Ebert, O1 |
---|---|
Zdroj: | Cancer Gene Therapy. Jun2015, Vol. 22 Issue 6, p317-325. 9p. 1 Chart, 6 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |